Literature DB >> 16548522

DAPT-induced intracellular accumulations of longer amyloid beta-proteins: further implications for the mechanism of intramembrane cleavage by gamma-secretase.

Sousuke Yagishita1, Maho Morishima-Kawashima, Yu Tanimura, Shoichi Ishiura, Yasuo Ihara.   

Abstract

Gamma-secretase cleaves the transmembrane domain of beta-amyloid precursor protein at multiple sites. These are referred to as gamma-, zeta-, and epsilon-cleavages. We showed previously that DAPT, a potent dipeptide gamma-secretase inhibitor, caused differential accumulations of longer amyloid beta-proteins (Abetas) (Abeta43 and Abeta46) in CHO cells that are induced to express the beta C-terminal fragment (CTF). To learn more about the cleavage mechanism by gamma-secretase, CHO cell lines coexpressing betaCTF and wild-type or mutant presenilin (PS) 1/2 were generated and treated with DAPT. In all cell lines treated with DAPT, as the levels of Abeta40 decreased, Abeta46 accumulated to varying extents. In wild-type PS1 or M146L mutant PS1 cells, substantial amounts of Abeta43 and Abeta46 accumulated. In contrast, this was not the case with wild-type PS2 cells. In M233T mutant PS1 cells, significant amounts of Abeta46 and Abeta48 accumulated differentially, whereas in N141I mutant PS2 cells, large amounts of Abeta45 accumulated concomitantly with a large decrease in Abeta42 levels. Most interestingly, in G384A mutant PS1 cells, there were no significant accumulations of longer Abetas except for Abeta46. Abeta40 was very susceptible to DAPT, but other Abetas were variably resistant. Complicated suppression and accumulation patterns by DAPT may be explained by stepwise processing of betaCTF from a zeta- or epsilon-cleavage site to a gamma-cleavage site and its preferential suppression of gamma-cleavage over zeta- or epsilon-cleavage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548522     DOI: 10.1021/bi0521846

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

Review 1.  Structure and mechanism of intramembrane protease.

Authors:  Ya Ha
Journal:  Semin Cell Dev Biol       Date:  2008-11-19       Impact factor: 7.727

2.  γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.

Authors:  Yong Ran; Pedro E Cruz; Thomas B Ladd; Abdul H Fauq; Joo In Jung; Julian Matthews; Kevin M Felsenstein; Todd E Golde
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

Review 3.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

Review 4.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Bart De Strooper
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

Review 5.  When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Michael S Wolfe
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

6.  5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease.

Authors:  Omidreza Firuzi; Jiamin Zhuo; Cinzia M Chinnici; Thomas Wisniewski; Domenico Praticò
Journal:  FASEB J       Date:  2007-11-12       Impact factor: 5.191

7.  An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.

Authors:  Carlo Sala Frigerio; Thomas L Kukar; Abdul Fauq; Paul C Engel; Todd E Golde; Dominic M Walsh
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

8.  Stable insertion of Alzheimer Abeta peptide into the ER membrane strongly correlates with its length.

Authors:  Carolina Lundin; Sofia Johansson; Arthur E Johnson; Jan Näslund; Gunnar von Heijne; IngMarie Nilsson
Journal:  FEBS Lett       Date:  2007-07-19       Impact factor: 4.124

9.  Major carboxyl terminal fragments generated by γ-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long.

Authors:  Inga Pinnix; Jorge A Ghiso; Miguel A Pappolla; Kumar Sambamurti
Journal:  Am J Geriatr Psychiatry       Date:  2013-05       Impact factor: 4.105

10.  Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts.

Authors:  Graziella Mendonsa; Justyna Dobrowolska; Angela Lin; Pooja Vijairania; Y-J I Jong; Nancy L Baenziger
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.